These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 12846760)

  • 1. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.
    Vasavada N; Saha C; Agarwal R
    Kidney Int; 2003 Aug; 64(2):632-40. PubMed ID: 12846760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of excess volume in the pathophysiology of hypertension in chronic kidney disease.
    Vasavada N; Agarwal R
    Kidney Int; 2003 Nov; 64(5):1772-9. PubMed ID: 14531810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA; Banta WM
    Ann Pharmacother; 2009 Nov; 43(11):1836-47. PubMed ID: 19843838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge?
    Yao Y; Zhang J; Zhang Y; Zhang R
    Int Heart J; 2018 Jul; 59(4):813-820. PubMed ID: 29877310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
    Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-week study of torsemide in patients with congestive heart failure.
    Goebel KM
    Clin Ther; 1993; 15(6):1051-9. PubMed ID: 8111802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency.
    Rudy DW; Gehr TW; Matzke GR; Kramer WG; Sica DA; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):39-47. PubMed ID: 8033493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
    Dodion L; Ambroes Y; Lameire N
    Eur J Clin Pharmacol; 1986; 31 Suppl():21-7. PubMed ID: 3780837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
    Mentz RJ; Velazquez EJ; Metra M; McKendry C; Chiswell K; Fiuzat M; Givertz MM; Voors AA; Teerlink JR; O'Connor CM
    Future Cardiol; 2015 Sep; 11(5):585-95. PubMed ID: 26403536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients.
    Vargas Hein O; Staegemann M; Wagner D; von Heymann C; Martin M; Morgera S; Spies C
    Ren Fail; 2005; 27(4):385-92. PubMed ID: 16060124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
    Ballester MR; Roig E; Gich I; Puntes M; Delgadillo J; Santos B; Antonijoan RM
    Drug Des Devel Ther; 2015; 9():4291-302. PubMed ID: 26273191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
    Scheen AJ; Vancrombreucq JC; Delarge J; Luyckx AS
    Eur J Clin Pharmacol; 1986; 31 Suppl():35-42. PubMed ID: 3780838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites.
    Abecasis R; Guevara M; Miguez C; Cobas S; Terg R
    Scand J Gastroenterol; 2001 Mar; 36(3):309-13. PubMed ID: 11305520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response study of orally administered torsemide in patients with ascites due to cirrhosis.
    Applefeld JJ; Kasmer RJ; Hak LJ; Dukes GE; Wermeling DP; McClain CJ
    Aliment Pharmacol Ther; 1994 Aug; 8(4):397-402. PubMed ID: 7986964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
    Gerbes AL; Bertheau-Reitha U; Falkner C; Jüngst D; Paumgartner G
    J Hepatol; 1993 Mar; 17(3):353-8. PubMed ID: 8315263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group.
    Patterson JH; Adams KF; Applefeld MM; Corder CN; Masse BR
    Pharmacotherapy; 1994; 14(5):514-21. PubMed ID: 7997385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
    Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
    Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.